Carbohydrates proteins lipid nucleotide hb enzymes biological oxidation mineral cell in sabko important or inme bhi most important topic jo university exam me puche jate h uske hisab se urrange karo with clinical desease sara kuch
MBBS 1st year biochemistry university exam most important topics carbohydrates proteins lipids nucleotides enzymes
https://www.diginerve.com/blogs/important-topics-for-biochemβ¦
| Rank | Topic | Clinical Disease |
|---|---|---|
| 1 | Glycolysis (10 steps, enzymes, energy yield) | Pyruvate kinase deficiency - Hemolytic anemia |
| 2 | TCA Cycle / Krebs Cycle (8 steps, 3 NADH, 1 FADH2) | Thiamine (B1) deficiency - Beriberi, Wernicke's encephalopathy |
| 3 | Gluconeogenesis (substrates, key enzymes, bypass points) | Hypoglycemia, Diabetes mellitus |
| 4 | Glycogen metabolism (synthesis + degradation) | Von Gierke's (Type I), Pompe's (Type II), McArdle's (Type V) - Glycogen Storage Diseases |
| 5 | HMP Shunt / Pentose Phosphate Pathway | G6PD deficiency - Hemolytic anemia (favism), NADPH role |
| 6 | Blood glucose regulation (insulin, glucagon) | Diabetes mellitus (Type 1 & 2), Hypoglycemia |
| 7 | Lactose intolerance | Lactase deficiency - bloating, diarrhea |
| 8 | Fructose & Galactose metabolism | Essential fructosuria, Fructose intolerance, Galactosemia - Cataracts, liver damage |
| Rank | Topic | Clinical Relevance |
|---|---|---|
| 1 | Enzyme kinetics (Km, Vmax, Michaelis-Menten equation) | Drug target understanding |
| 2 | Enzyme inhibition (Competitive, Non-competitive, Uncompetitive) | Drug mechanisms - Statins, Sulfonamides, Aspirin |
| 3 | Allosteric enzymes (cooperative kinetics, sigmoidal curve) | Regulatory enzymes in metabolism |
| 4 | Isoenzymes | LDH-1 (MI diagnosis), LDH-5 (liver), CK-MB (cardiac) |
| 5 | Coenzymes (B vitamins as coenzymes) | Pellagra (NAD+), Beriberi (TPP), Riboflavin def (FAD) |
| 6 | Regulation of enzyme activity | Phosphorylation, allosterism |
| 7 | Plasma marker enzymes | AST/ALT - Hepatitis, Amylase/Lipase - Pancreatitis, ALP - Bone/Liver disease |
| Rank | Topic | Clinical Disease |
|---|---|---|
| 1 | Levels of protein structure (1Β°, 2Β°, 3Β°, 4Β°) | Misfolding - Prion diseases, Alzheimer's |
| 2 | Collagen structure & synthesis (triple helix, hydroxylation) | Scurvy (Vit C deficiency), Osteogenesis imperfecta, Ehlers-Danlos syndrome |
| 3 | Amino acid classification (essential, non-essential, charged) | Phenylketonuria (PKU), Alkaptonuria, Maple syrup urine disease |
| 4 | Protein denaturation | Fever, autoclaving, alpha-helix disruption |
| 5 | Plasma proteins (Albumin, Globulins, role) | Hypoalbuminemia - Edema; Multiple myeloma (M-protein) |
| 6 | Protein digestion & absorption | Hartnup disease, Cystinuria |
| 7 | Protein energy malnutrition | Kwashiorkor (protein deficiency), Marasmus (calorie deficiency) |
| Disorder | Defect | Feature |
|---|---|---|
| PKU | Phenylalanine hydroxylase | Mental retardation, mousy odor |
| Alkaptonuria | Homogentisate oxidase | Dark urine, ochronosis, arthritis |
| Albinism | Tyrosinase | No melanin, sun sensitivity |
| Maple Syrup Urine Disease | BCAA decarboxylase | Sweet urine, neurological damage |
| Homocystinuria | Cystathionine synthase | Lens dislocation, thrombosis |
| Rank | Topic | Clinical Disease |
|---|---|---|
| 1 | Beta oxidation of fatty acids (steps, energy calculation) | Zellweger syndrome, MCAD deficiency - Hypoglycemia |
| 2 | Ketone body metabolism (synthesis + utilization) | Diabetic ketoacidosis (DKA), starvation ketosis |
| 3 | Cholesterol synthesis (HMG-CoA pathway) | Hypercholesterolemia - Atherosclerosis, CAD |
| 4 | Lipoproteins (VLDL, LDL, HDL, chylomicrons - structure + function) | Hyperlipoproteinemias (Fredrickson classification) |
| 5 | Fatty acid synthesis (malonyl CoA, FAS complex) | Obesity pathways |
| 6 | Phospholipids & Sphingolipids | Niemann-Pick, Gaucher's, Tay-Sachs disease |
| 7 | Prostaglandins | NSAIDs mechanism (COX inhibition), inflammation |
| Rank | Topic | Clinical Disease |
|---|---|---|
| 1 | Structure of Hb (alpha-2 beta-2 chains, heme group) | Normal vs abnormal Hb |
| 2 | O2 dissociation curve (sigmoidal, Bohr effect, 2,3-BPG) | Altitude adaptation, CO poisoning (left shift) |
| 3 | Sickle cell disease (HbS, point mutation valβglu) | Vaso-occlusive crisis, hemolytic anemia, splenomegaly |
| 4 | Thalassemia (alpha & beta types, gene deletions) | Microcytic anemia, Cooley's anemia, hydrops fetalis |
| 5 | Methemoglobin (Fe3+ form) | Cyanosis, treated with methylene blue |
| 6 | Myoglobin vs Hemoglobin (hyperbolic vs sigmoidal curve) | Myocardial infarction (myoglobin as early marker) |
| 7 | HbF vs HbA | HPFH (Hereditary Persistence of Fetal Hemoglobin) |
| 8 | Heme synthesis & Porphyrias | Lead poisoning (ALA dehydratase inhibition), Acute intermittent porphyria |
| Rank | Topic | Clinical Disease |
|---|---|---|
| 1 | Purine synthesis (de novo + salvage pathway) | Gout (uric acid excess), Lesch-Nyhan syndrome |
| 2 | Pyrimidine synthesis | Orotic aciduria |
| 3 | DNA structure (Watson-Crick model, A-T:G-C base pairing) | Mutations, UV damage |
| 4 | DNA replication (semi-conservative, enzymes involved) | Cancer, antibiotic targets |
| 5 | RNA types (mRNA, tRNA, rRNA) + Transcription | Ribozymes, mRNA processing |
| 6 | Drugs affecting nucleotide metabolism | Allopurinol (gout), Methotrexate (folate antagonist), 5-FU (cancer) |
| Rank | Topic | Clinical Disease |
|---|---|---|
| 1 | Electron Transport Chain (ETC) (Complex I-IV, ATP synthesis) | Mitochondrial diseases |
| 2 | Oxidative Phosphorylation (Chemiosmotic theory, Mitchell) | Uncouplers - DNP, thermogenin (brown fat) |
| 3 | ATP yield calculations | NADH = 2.5 ATP; FADH2 = 1.5 ATP |
| 4 | Inhibitors of ETC | Rotenone (Cx I), Cyanide (Cx IV) - poisoning |
| 5 | Free radicals & antioxidants | Superoxide dismutase (SOD), Catalase, Vit E, Vit C |
| 6 | P:O ratio & energy coupling | Uncoupling in fever/thermogenesis |
| Rank | Mineral | Clinical Disease |
|---|---|---|
| 1 | Iron - absorption, transport (transferrin), storage (ferritin) | Iron deficiency anemia, Hemochromatosis (iron overload) |
| 2 | Calcium & Phosphorus - PTH, Vitamin D regulation | Hypocalcemia (tetany), Rickets (Vit D def), Osteoporosis |
| 3 | Iodine | Hypothyroidism, Goiter, Cretinism (congenital) |
| 4 | Zinc | Acrodermatitis enteropathica, wound healing delay, hypogonadism |
| 5 | Copper | Wilson's disease (copper excess - liver, brain, Kayser-Fleischer rings), Menkes disease |
| 6 | Fluoride | Dental caries prevention; Fluorosis (mottled teeth) excess |
| 7 | Selenium | Keshan disease (cardiomyopathy), part of glutathione peroxidase |
| 8 | Magnesium | Hypomagnesemia - arrhythmias, tetany |
| Rank | Topic | Clinical Relevance |
|---|---|---|
| 1 | Cell membrane (fluid mosaic model, lipid bilayer) | Membrane transport disorders |
| 2 | Mitochondria (structure + function - powerhouse) | Mitochondrial myopathies, MELAS syndrome |
| 3 | Nucleus & Nucleolus | Gene expression, Cancer |
| 4 | Ribosomes (70S vs 80S) | Antibiotic targets (aminoglycosides, tetracyclines - 30S; macrolides, chloramphenicol - 50S) |
| 5 | Lysosomes | Lysosomal storage diseases (Gaucher's, Hurler's, Tay-Sachs) |
| 6 | Golgi apparatus | Protein glycosylation, secretion pathway |
| 7 | Peroxisomes | Zellweger syndrome, fatty acid oxidation |
| 8 | Cell signaling | Receptor types, second messengers (cAMP, IP3, Ca2+) |
| Priority | Topic | Marks Weightage | Exam Frequency |
|---|---|---|---|
| π΄ 1st | Carbohydrates | 30-35 marks | Har exam |
| π΄ 2nd | Enzymes | 25-30 marks | Har exam |
| π΄ 3rd | Proteins | 20-25 marks | Har exam |
| π 4th | Lipids | 20-25 marks | Frequently |
| π 5th | Hemoglobin | 15-20 marks | Frequently |
| π‘ 6th | Nucleotides | 10-15 marks | Often |
| π‘ 7th | Biological Oxidation | 10-15 marks | Often |
| π‘ 8th | Minerals | 10-12 marks | Short notes |
| π‘ 9th | Cell | 8-10 marks | Viva/Practical |
| Disease | Biochemical Defect | Topic |
|---|---|---|
| Phenylketonuria (PKU) | Phe hydroxylase | Amino acids |
| Alkaptonuria | Homogentisate oxidase | Amino acids |
| Sickle cell anemia | HbS (ValβGlu in beta chain) | Hemoglobin |
| Thalassemia | Globin chain synthesis defect | Hemoglobin |
| Gout | Uric acid excess (XO activity) | Nucleotides |
| Lesch-Nyhan | HGPRT deficiency | Nucleotides |
| Gaucher's | Glucocerebrosidase | Lipids/Lysosomes |
| Tay-Sachs | Hexosaminidase A | Lipids/Lysosomes |
| Von Gierke's | Glucose-6-phosphatase | Carbohydrates |
| Scurvy | Vit C def (collagen hydroxylation) | Proteins |
| Rickets | Vit D deficiency | Minerals |
| Wilson's disease | Ceruloplasmin/ATP7B defect | Minerals |
| Beriberi | Thiamine (B1) deficiency | Carbohydrates |
| Cyanide poisoning | Complex IV inhibition | Bio oxidation |
| DKA | Insulin deficiency - ketosis | Lipids |
inko bhi or short karo 5 topic in each chapter
| # | Topic | Clinical Disease |
|---|---|---|
| 1 | Glycolysis - 10 steps, energy yield | Pyruvate kinase deficiency β Hemolytic anemia |
| 2 | TCA Cycle - 8 steps, NADH/FADH2 | Thiamine def β Beriberi, Wernicke's |
| 3 | Gluconeogenesis - substrates, bypass enzymes | Hypoglycemia, Diabetes |
| 4 | Glycogen Storage - synthesis + degradation | Von Gierke's, Pompe's, McArdle's |
| 5 | HMP Shunt - NADPH, pentose sugars | G6PD deficiency β Hemolytic anemia |
| # | Topic | Clinical Disease |
|---|---|---|
| 1 | Protein Structure - 1Β°, 2Β°, 3Β°, 4Β° levels | Prion disease, Alzheimer's (misfolding) |
| 2 | Collagen Synthesis - triple helix, hydroxylation | Scurvy, Osteogenesis imperfecta |
| 3 | Amino Acid Disorders - PKU, Alkaptonuria | PKU β mental retardation; Alkaptonuria β dark urine |
| 4 | Plasma Proteins - albumin, globulins | Hypoalbuminemia β edema; Multiple myeloma |
| 5 | Protein Energy Malnutrition | Kwashiorkor (protein def), Marasmus (calorie def) |
| # | Topic | Clinical Disease |
|---|---|---|
| 1 | Beta Oxidation - steps, ATP calculation | MCAD deficiency β Hypoglycemia |
| 2 | Ketone Body Metabolism | DKA (Diabetic Ketoacidosis), Starvation |
| 3 | Cholesterol Synthesis - HMG-CoA pathway | Hypercholesterolemia β Atherosclerosis, CAD |
| 4 | Lipoproteins - VLDL, LDL, HDL, Chylomicrons | Hyperlipoproteinemias; Statin drugs (HMG-CoA inhibitors) |
| 5 | Sphingolipids - structure + metabolism | Gaucher's, Tay-Sachs, Niemann-Pick disease |
| # | Topic | Clinical Disease |
|---|---|---|
| 1 | Michaelis-Menten Kinetics - Km, Vmax, graph | Drug design (competitive inhibitors) |
| 2 | Enzyme Inhibition - competitive vs non-competitive | Statins, Sulfonamides, Aspirin mechanism |
| 3 | Isoenzymes - LDH, CK types | LDH-1 β MI; CK-MB β Cardiac; LDH-5 β Liver |
| 4 | Allosteric Enzymes - sigmoidal curve, regulation | Rate-limiting step control in metabolism |
| 5 | Plasma Marker Enzymes | ALT/AST β Hepatitis; Amylase β Pancreatitis; ALP β Liver/Bone |
| # | Topic | Clinical Disease |
|---|---|---|
| 1 | Hb Structure - alpha-2 beta-2, heme group | Normal vs abnormal variants |
| 2 | O2 Dissociation Curve - Bohr effect, 2,3-BPG | CO poisoning β left shift; Altitude β right shift |
| 3 | Sickle Cell Disease - HbS, ValβGlu mutation | Vaso-occlusive crisis, hemolytic anemia |
| 4 | Thalassemia - alpha/beta types | Microcytic anemia, Cooley's anemia, hydrops fetalis |
| 5 | Heme Synthesis + Porphyrias | Lead poisoning β ALA dehydratase inhibition |
| # | Topic | Clinical Disease |
|---|---|---|
| 1 | Purine Synthesis - de novo + salvage pathway | Gout (uric acid excess) |
| 2 | Lesch-Nyhan Syndrome - HGPRT deficiency | Self-mutilation, gout, hyperuricemia |
| 3 | DNA Structure - Watson-Crick, base pairing | Mutations, UV damage |
| 4 | DNA Replication - semi-conservative, enzymes | Cancer targets, antibiotics |
| 5 | Drugs on Nucleotide Metabolism | Allopurinol β Gout; Methotrexate β Cancer; 5-FU |
| # | Topic | Clinical Disease |
|---|---|---|
| 1 | ETC - Complex I-IV, electron flow | Mitochondrial myopathies |
| 2 | Oxidative Phosphorylation - Chemiosmotic theory | Uncouplers β DNP (illegal weight loss), Thermogenin |
| 3 | ATP Yield - NADH=2.5, FADH2=1.5 ATP | Energy calculations in metabolism |
| 4 | ETC Inhibitors | Cyanide β Complex IV; Rotenone β Complex I (poisoning) |
| 5 | Free Radicals + Antioxidants - SOD, Catalase | Oxidative stress β Cancer, aging, reperfusion injury |
| # | Mineral | Clinical Disease |
|---|---|---|
| 1 | Iron - absorption, transferrin, ferritin | Iron deficiency anemia; Hemochromatosis (overload) |
| 2 | Calcium + Vit D - PTH regulation | Rickets, Tetany, Osteoporosis |
| 3 | Iodine | Hypothyroidism, Goiter, Cretinism |
| 4 | Copper - ceruloplasmin | Wilson's disease (KF rings, liver cirrhosis); Menkes disease |
| 5 | Zinc | Acrodermatitis enteropathica, poor wound healing |
| # | Topic | Clinical Relevance |
|---|---|---|
| 1 | Cell Membrane - fluid mosaic model | Transport disorders, receptor defects |
| 2 | Mitochondria - structure, ETC location | MELAS syndrome, mitochondrial myopathies |
| 3 | Lysosomes - hydrolytic enzymes | Gaucher's, Tay-Sachs, Hurler's (storage diseases) |
| 4 | Ribosomes - 70S vs 80S | Antibiotic targets (30S β aminoglycosides; 50S β macrolides) |
| 5 | Peroxisomes - beta oxidation (very long FA) | Zellweger syndrome |
Carbohydrates + Enzymes + Proteins = 60% of paper Lipids + Hb = 25% of paper Rest = 15% (Short notes + Viva)